AMBROSINI, Elisa
 Distribuzione geografica
Continente #
EU - Europa 224
NA - Nord America 64
AS - Asia 61
SA - Sud America 22
AF - Africa 14
OC - Oceania 1
Totale 386
Nazione #
IT - Italia 135
US - Stati Uniti d'America 64
CN - Cina 25
RU - Federazione Russa 24
NL - Olanda 21
BR - Brasile 19
HK - Hong Kong 19
SG - Singapore 13
DE - Germania 9
CI - Costa d'Avorio 8
FI - Finlandia 7
AT - Austria 6
FR - Francia 6
IE - Irlanda 5
MA - Marocco 5
SE - Svezia 4
EC - Ecuador 2
KR - Corea 2
AR - Argentina 1
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GB - Regno Unito 1
IR - Iran 1
LT - Lituania 1
PL - Polonia 1
PS - Palestinian Territory 1
UA - Ucraina 1
Totale 386
Città #
Hong Kong 19
Ancona 16
Boardman 13
Macerata 12
Tolentino 10
Moscow 9
Abidjan 8
Chandler 8
Milan 8
Xi'an 8
Singapore 7
Ningbo 6
Perugia 6
Cascina 5
Dublin 5
Rome 5
São Paulo 5
Des Moines 4
Easley 4
Mugnano di Napoli 4
Nuremberg 4
The Dalles 4
Turku 4
Helsinki 3
Naples 3
New York 3
Osimo 3
Vienna 3
Amsterdam 2
Beijing 2
Los Angeles 2
Munich 2
North Bergen 2
Orange 2
Porto Recanati 2
Seattle 2
Wuhan 2
Aparecida de Goiânia 1
Araucária 1
Ascoli Piceno 1
Ashburn 1
Blumenau 1
Boa Viagem 1
Boston 1
Brooklyn 1
Cairo 1
Campo Mourão 1
Chelyabinsk 1
Chicago 1
Conselheiro Lafaiete 1
Copenhagen 1
Falconara Marittima 1
Florence 1
Grünwald 1
Guarujá 1
Guayaquil 1
Huizhou 1
Hurlingham 1
Jales 1
Lawrence 1
Liberty Lake 1
London 1
Magé 1
Montecosaro 1
Nova Prata 1
Olomouc 1
Phoenix 1
Porto Sant'Elpidio 1
Princeton 1
Ramallah 1
Red Oak 1
San Diego 1
San Jose 1
Santo Domingo de los Colorados 1
Sarandi 1
Secaucus 1
Seoul 1
Shanghai 1
Simferopol 1
Sparks 1
São Gonçalo do Amarante 1
Turin 1
Vallefoglia 1
Varginha 1
Vitória de Santo Antão 1
Warsaw 1
Yiwu 1
Zhongshan 1
Zibo 1
Zurich 1
Totale 260
Nome #
1621P miRNA signature as early predictor of hyponatremia and survival in lung cancer: Preliminary results from the ISA retrospective study 69
85P NSCLC-Pro ClustAI: A machine learning model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 66
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671) 53
NSCLC-Pro ClustAI: A Machine Learning Model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 51
miRNA signature as early predictor of hyponatremia and survival in lung cancer: preliminary results from the ISA retrospective study 44
BRCA mutations and gastrointestinal cancers: When to expect the unexpected? 43
Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine 37
The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy 30
Studio e ricerca di biomarcatori correlati con l’iponatriemia nei pazienti con tumore al polmone: genotipizzazione dei polimorfismi a singolo nucleotide ed analisi di espressione dei microRNA e dei recettori della vasopressina. 18
Totale 411
Categoria #
all - tutte 1.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 0 0 0 0 0 4 1 0 1
2022/202318 1 3 1 1 3 3 0 0 4 0 2 0
2023/202478 2 0 0 1 6 2 0 0 0 0 1 66
2024/2025309 20 15 55 16 28 10 22 15 61 40 25 2
Totale 411